logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 6
  • 1
    Tate, Jason Rodney
    Born in May 1976
    Individual (6 offsprings)
    Officer
    2022-06-14 ~ now
    OF - Director → CIF 0
  • 2
    Ruprai, Leanna
    Born in April 1993
    Individual (3 offsprings)
    Officer
    2025-10-01 ~ now
    OF - Director → CIF 0
  • 3
    Ruprai, Gurdev Singh
    Born in July 1960
    Individual (27 offsprings)
    Officer
    2020-12-23 ~ now
    OF - Director → CIF 0
    Mr Gurdev Singh Ruprai
    Born in July 1960
    Individual (27 offsprings)
    Person with significant control
    2020-12-23 ~ 2022-01-01
    PE - Ownership of shares – 75% or more → CIF 0
  • 4
    Ruprai, Roshan
    Born in April 1998
    Individual (3 offsprings)
    Officer
    2025-06-16 ~ now
    OF - Director → CIF 0
  • 5
    Ruprai, Nikisha
    Born in October 1991
    Individual (3 offsprings)
    Officer
    2025-06-16 ~ now
    OF - Director → CIF 0
  • 6
    ENNOGEN INVESTMENTS LTD
    13266253
    Unit G4, Riverside Way, Dartford, England
    Active Corporate (3 parents, 5 offsprings)
    Person with significant control
    2022-01-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

ENNOGEN HEALTHCARE INTERNATIONAL LIMITED

Period: 2020-12-23 ~ now
Company number: 13097275
Registered name
ENNOGEN HEALTHCARE INTERNATIONAL LIMITED - now
Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
542024-01-01 ~ 2024-12-31
472023-01-01 ~ 2023-12-31
Turnover/Revenue
51,914,110 GBP2024-01-01 ~ 2024-12-31
33,324,661 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
-16,833,585 GBP2024-01-01 ~ 2024-12-31
-13,148,669 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
35,080,525 GBP2024-01-01 ~ 2024-12-31
20,175,992 GBP2023-01-01 ~ 2023-12-31
Distribution Costs
-1,390,178 GBP2024-01-01 ~ 2024-12-31
-1,630,910 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-23,781,236 GBP2024-01-01 ~ 2024-12-31
-19,348,991 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
9,563,256 GBP2024-01-01 ~ 2024-12-31
-1,194,518 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
8,787,215 GBP2024-01-01 ~ 2024-12-31
-2,129,138 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
4,753,985 GBP2024-01-01 ~ 2024-12-31
-3,295,140 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
60,838,222 GBP2024-12-31
57,669,250 GBP2023-12-31
Property, Plant & Equipment
241,785 GBP2024-12-31
133,825 GBP2023-12-31
Fixed Assets - Investments
271,466 GBP2024-12-31
271,466 GBP2023-12-31
Fixed Assets
61,351,473 GBP2024-12-31
58,074,541 GBP2023-12-31
Total Inventories
9,819,515 GBP2024-12-31
6,784,966 GBP2023-12-31
Debtors
16,682,744 GBP2024-12-31
11,112,769 GBP2023-12-31
Cash at bank and in hand
9,876,703 GBP2024-12-31
3,153,260 GBP2023-12-31
Current Assets
36,378,962 GBP2024-12-31
21,050,995 GBP2023-12-31
Net Current Assets/Liabilities
1,011,049 GBP2024-12-31
-515,197 GBP2023-12-31
Total Assets Less Current Liabilities
62,362,522 GBP2024-12-31
57,559,344 GBP2023-12-31
Net Assets/Liabilities
62,302,076 GBP2024-12-31
57,525,888 GBP2023-12-31
Equity
Called up share capital
2,000 GBP2024-12-31
2,000 GBP2023-12-31
2,000 GBP2023-01-01
Share premium
62,399,000 GBP2024-12-31
62,399,000 GBP2023-12-31
62,399,000 GBP2023-01-01
Other miscellaneous reserve
92,203 GBP2024-12-31
Retained earnings (accumulated losses)
-191,127 GBP2024-12-31
-4,875,112 GBP2023-12-31
-1,484,972 GBP2023-01-01
Equity
62,302,076 GBP2024-12-31
57,525,888 GBP2023-12-31
60,916,028 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
4,753,985 GBP2024-01-01 ~ 2024-12-31
-3,295,140 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
4,683,985 GBP2024-01-01 ~ 2024-12-31
-3,390,140 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
4,683,985 GBP2024-01-01 ~ 2024-12-31
-3,390,140 GBP2023-01-01 ~ 2023-12-31
Wages/Salaries
3,473,668 GBP2024-01-01 ~ 2024-12-31
2,476,020 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
312,177 GBP2024-01-01 ~ 2024-12-31
233,014 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
3,963,994 GBP2024-01-01 ~ 2024-12-31
2,851,308 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
26,990 GBP2024-01-01 ~ 2024-12-31
33,456 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
2,196,804 GBP2024-01-01 ~ 2024-12-31
-500,785 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
88,284,905 GBP2024-12-31
72,226,031 GBP2023-12-31
Development expenditure
2,152,475 GBP2024-12-31
323,092 GBP2023-12-31
Intangible Assets - Gross Cost
91,004,622 GBP2024-12-31
72,549,123 GBP2023-12-31
Computer software
567,242 GBP2024-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
30,128,584 GBP2024-12-31
14,879,873 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
30,166,400 GBP2024-12-31
14,879,873 GBP2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
15,286,527 GBP2024-01-01 ~ 2024-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
58,156,321 GBP2024-12-31
57,346,158 GBP2023-12-31
Development expenditure
2,152,475 GBP2024-12-31
323,092 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
234,481 GBP2024-12-31
106,619 GBP2023-12-31
Furniture and fittings
23,704 GBP2024-12-31
14,914 GBP2023-12-31
Computers
55,896 GBP2024-12-31
26,418 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
314,081 GBP2024-12-31
147,951 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
41,028 GBP2024-12-31
1,777 GBP2023-12-31
Furniture and fittings
10,334 GBP2024-12-31
4,703 GBP2023-12-31
Computers
20,934 GBP2024-12-31
7,646 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
72,296 GBP2024-12-31
14,126 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
39,251 GBP2024-01-01 ~ 2024-12-31
Computers, Owned/Freehold
13,288 GBP2024-01-01 ~ 2024-12-31
Owned/Freehold
58,170 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Plant and equipment
193,453 GBP2024-12-31
104,842 GBP2023-12-31
Furniture and fittings
13,370 GBP2024-12-31
10,211 GBP2023-12-31
Computers
34,962 GBP2024-12-31
18,772 GBP2023-12-31
Raw materials and consumables
2,631,915 GBP2024-12-31
761,737 GBP2023-12-31
Finished Goods/Goods for Resale
7,187,600 GBP2024-12-31
6,023,229 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
13,715,174 GBP2024-12-31
10,387,374 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
2,072,480 GBP2024-12-31
247,253 GBP2023-12-31
Other Debtors
Current
531,944 GBP2024-12-31
299,402 GBP2023-12-31
Prepayments/Accrued Income
Current
363,146 GBP2024-12-31
178,740 GBP2023-12-31
Debtors
Current
16,682,744 GBP2024-12-31
11,112,769 GBP2023-12-31
Cash and Cash Equivalents
9,876,703 GBP2024-12-31
3,153,260 GBP2023-12-31
Bank Borrowings
Current
15,125,000 GBP2024-12-31
7,750,000 GBP2023-12-31
Trade Creditors/Trade Payables
Current
1,419,778 GBP2024-12-31
794,029 GBP2023-12-31
Amounts owed to group undertakings
Current
12,876,940 GBP2024-12-31
8,406,034 GBP2023-12-31
Corporation Tax Payable
Current
2,873,694 GBP2024-12-31
1,132,546 GBP2023-12-31
Taxation/Social Security Payable
Current
80,215 GBP2024-12-31
859,376 GBP2023-12-31
Other Creditors
Current
9,583 GBP2024-12-31
13,811 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
2,982,703 GBP2024-12-31
2,610,396 GBP2023-12-31
Creditors
Current
35,367,913 GBP2024-12-31
21,566,192 GBP2023-12-31
Net Deferred Tax Liability/Asset
-60,446 GBP2024-12-31
-33,456 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2,000 shares2024-12-31
2,000 shares2023-12-31
Par Value of Share
Class 1 ordinary share
1.002024-01-01 ~ 2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
26,538 GBP2024-12-31
15,839 GBP2023-12-31
Between one and five year
66,552 GBP2024-12-31
64,514 GBP2023-12-31
More than five year
50,600 GBP2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
143,690 GBP2024-12-31
80,353 GBP2023-12-31
Related profiles found in government register
  • ENNOGEN HEALTHCARE INTERNATIONAL LIMITED
    Info
    Registered number 13097275
    Unit G4 Riverside Industrial Estate, Riverside Way, Dartford, Kent DA1 5BS
    PRIVATE LIMITED COMPANY incorporated on 2020-12-23 (5 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-12-22
    CIF 0
  • ENNOGEN HEALTHCARE INTERNATIONAL LIMITED
    S
    Registered number 13097275
    Unit G4, Riverside Way, Dartford, England, DA1 5BS
    Private Limited Company in Companies House, England
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    VITAME LTD
    08871470
    Unit G4 Riverside Indl Estate Riverside Way, Riverside Way, Dartford
    Active Corporate (2 parents)
    Person with significant control
    2022-12-21 ~ now
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.